Insulin metabolism in hypothalamic obesity

Area of Science:

• Endocrinology
• Pediatric Obesity
• Metabolic Research

Background:

• Obesity in children can stem from various causes, including hypothalamic dysfunction and hypercalorization.
• Understanding the underlying hormonal and metabolic profiles is crucial for effective management.
• Insulin resistance and hyperinsulinism are common in obesity, but their primary drivers can differ.

Purpose of the Study:

• To investigate the role of C-peptide and insulin levels in children with hypothalamic obesity versus those with obesity due to hypercalorization.
• To compare erythrocyte insulin binding capacity and percentage in these groups with ideal-weight controls.
• To determine if hyperinsulinism in hypothalamic obesity is a primary or secondary phenomenon.

Main Methods:

• Measured serum C-peptide and immunoreactive insulin (IRI) during oral glucose tolerance tests.
• Assessed fasting specific insulin binding percentage and capacity of erythrocytes.
• Calculated integral values of curves (sigma) and sigma C-peptide/sigma IRI ratios.
• Compared data between hypothalamic obesity, hypercalorization obesity, and ideal-weight control groups.

Main Results:

• Four cases of hypothalamic obesity exhibited substantially increased fasting C-peptide levels.
• The sigma C-peptide/sigma IRI ratio was normal or increased in the studied groups.
• Erythrocyte insulin binding percentage was comparable to the control group, correlating with normal or favorable glucose metabolism.
• Elevated fasting C-peptide in obese children may suggest hypothalamic-pituitary system dysfunction.

Conclusions:

• Hyperinsulinism in diencephalic (hypothalamic) obesity appears to be a primary condition.
• Normal erythrocyte insulin binding suggests preserved glucose metabolism despite obesity in these cases.
• High fasting C-peptide levels in obese children warrant further investigation of the hypothalamic-pituitary system.